Article
Two rare confounding polymorphisms proximal to the factor V Leiden mutation.
Molecular diagnosis : a journal devoted to the understanding of human disease through the clinical application of molecular biology - 1 Jun 2001
Gold B, Hanson M, Dean M
Abstract excerpt
BACKGROUND: Comprehensive assessment of thrombophilia risk includes characterization of the R506Q (Leiden) mutation in factor V in many patients. Although activated protein C resistance is often assessed by means of a coagulation test, molecular interrogation of the G1691A mutation provides confi...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
